Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

ConvaVAC Ag+ NPWT for Venous Leg Ulcers

Official title: A Study to Determine the Safety and Performance of ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds

Run by ConvaTec Inc. · NCT07342049 · Data updated 2026-11-12

This trial tests whether the ConvaVAC Ag+ Negative Pressure Wound Therapy system can safely help heal venous leg ulcers.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment87 (estimated)
SponsorConvaTec Inc.
Industry-sponsored
Drugs / interventionschemotherapy, immunotherapy, radiation
Locations7 sites (Santiago, Santiago Metropolitan and 6 other locations)
StatusRecruiting
StartedJanuary 12, 2026
Main results expectedOctober 30, 2026
Study endsOctober 30, 2026
Registry record updatedJuly 9, 2026
Trial IDNCT07342049 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with venous leg ulcers that can be treated with NPWT, with at least one sign of infection, and without contraindicating conditions.

Probably not a fit

Patients with wounds outside the specified size or depth range, without infection, or with contraindicating conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the safety and effectiveness of the ConvaVAC Ag+ NPWT system in treating chronic venous leg ulcers. Eligible participants are adults with VLUs that are amenable to negative pressure therapy and show signs of infection. Wounds will be managed with the ConvaVAC device to assess healing outcomes and potential reductions in infection risk. The study emphasizes chronic wounds’ burden on patients and healthcare systems and aims to determine whether this therapy offers a meaningful benefit in healing time and wound quality.

Why it matters

Potential benefit: If successful, participants may experience faster wound healing and reduced infection, potentially improving symptoms and quality of life.

How similar studies have gone: Prior evidence suggests that silver-containing NPWT approaches can help manage infected chronic wounds, though results vary by wound type and patient.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A wound which is amenable to NPWT and is a VLU as defined by CEAP Classification of C6 or C6R
* Wounds that are clean or contaminated
* Wounds with at least one sign or symptom of infection
* Wounds that in the opinion of the investigator would benefit from an antimicrobial dressing
* ≥18 years old at the time of consent

Exclusion Criteria:

* Known sensitivities or allergies to components of the ConvaVAC™ Ag+ NPWT System
* Ischemic wounds with necrotic tissue or eschar present that require sharp debridement
* Wound is too small or too large based on wound dressing size (\> 0.5cm2 and \< 100cm2)
* Wound depth \>7cm
* Wounds requiring concomitant use of DuoDERM® gel, hydrogels, petroleum-based creams/ ointment-/gels per the opinion of the investigator
* Active chemotherapy, radiation therapy, or immunotherapy for cancer or completed treatment within the last 3 months
* Any active malignancy at site of dressing application
* Exposed bone in target wound
* Exposed blood vessels or nerves in target wound
* Systemic infection and/or systemic inflammatory response syndrome (SIRS), sepsis
* Cellulitis in target wound
* Untreated deep tissue infection including but not limited to osteomyelitis, septic arthritis
* Active Pregnancy
* Subjects that in the opinion of the investigator are not suitable for enrollment
* Vulnerable subjects as determined by ICH Harmonized Guideline, Good Clinical Practice E6(R2)

Where it's running

  • ConvaCare Clinic
    Santiago, Santiago Metropolitan, Chile
    Recruiting
  • Middlewood Partnership
    Bollington, Cheshire, United Kingdom
    Recruiting
  • Knutsford Medical Partnership
    Knutsford, Cheshire, United Kingdom
    Recruiting
  • Dorset County Hospital NHS Foundation Trust
    Dorchester, Dorset, United Kingdom
    Recruiting
  • Assured Clinical Research Ltd
    Swaffham, Norfolk, United Kingdom
    Recruiting
  • Northumbria Healthcare NHS Foundation Trust
    Ashington, Northumberland, United Kingdom
    Recruiting
Show 1 more location
  • Nottingham University Hospitals NHS Trust
    Nottingham, Nottinghamshire, United Kingdom
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.